Document:

Executive Employment Agreement

 Exhibit 10.1 
  
 EXECUTIVE AGREEMENT 
  
 THIS EXECUTIVE AGREEMENT (the “Agreement”) is made effective as of the 21st day of June 2004 (the “Effective Date”) between
THOMAS R. EVANS, an individual resident of the State of New York (“Executive”), and BANKRATE, INC., a Florida corporation with its principal place of business located in North Palm Beach, Florida (the “Company”). 
  
 WHEREAS, the Company desires to engage Executive to perform certain
services for the Company, and Executive desires to accept said engagement from the Company; and 
  
 WHEREAS, the Company and Executive have agreed upon the terms and conditions of Executive’s engagement by the Company, and the parties desire
to express the terms and conditions in this Agreement; and 
  
 WHEREAS, the Company and Executive intend for this Agreement to supersede all agreements between Executive and the Company. 
  
 NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged and accepted, the parties hereby agree as follows: 
  
 1. Employment of Executive. The Company hereby employs Executive as its Chief Executive Officer for the term of this Agreement, and
Executive hereby accepts such employment by the Company, under the terms of this Agreement subject to termination pursuant to the provisions of Section 8 hereof. 
  
 2. Duties and Location. 
  
 A. Executive’s position and duties will consist of a position and duties normally associated with the position
identified in Section 1. Executive shall report to the Company’s Board of Directors. Executive shall devote his full business time to the Company’s business and shall not render to others any service of any kind for compensation or engage
in any activity which conflicts or interferes with the performance of his obligations under this Agreement without the express written consent of the Board; provided, however, that Executive may engage in non-profit or charitable activities which do
not involve substantial time and which do not materially interfere with his employment under this Agreement and which activities are not in competition with the Company as determined in the discretion of the Board of Directors of the Company and
those activities set forth on Addendum A hereto. At all relevant times during his employment hereunder, the Board of Directors shall nominate Executive as a director of the Company. 
  
 B. Executive agrees that he shall at all times faithfully and to the best of
his ability and experience perform all of the duties that may be required of him pursuant to the terms of this Agreement. 
  

 C. Executive will perform his services from the Company’s office in New York, NY. Executive
recognizes that his position will entail reasonable travel, but the Company cannot require Executive to relocate outside of the New York City metropolitan area without Executive’s consent. 
  
 3. Base Salary. Executive shall receive a base salary
commencing on the Effective Date and during his employment hereunder of $300,000 per annum (the “Base Salary”), which amount may be increased (but not decreased) annually at the discretion of the Compensation Committee of the Board (the
“Committee”). The Base Salary shall be paid to Executive by the Company in accordance with the Company’s regular payroll practice as in effect from time to time. 
  
 4. Annual Bonus. Executive will be eligible for an annual bonus. Executive will receive an annual bonus of at
least $50,000 for the remainder of the calendar year 2004 and shall have a target bonus in accordance with the Company’s Management Bonus Program of at least $100,000 per year thereafter, all to be paid in accordance with the Company’s
regular bonus practice as in effect from time to time. 
  
 5.
Stock Incentive. 
  
 A. Executive shall be eligible to
participate in the Company’ stock option, stock purchase, or other stock incentive plans which are generally available to executive officers of the Company and shall be eligible for the grant of stock options, restricted stock or other awards
there under in accordance with the terms and provisions of such plans. Upon the execution of this Agreement, and prior to July 1, 2004, the Company shall issue Executive 600,000 shares of the Company’s common stock with the following vesting
schedule: 
  

					
	 	  	200,000	  	July 1, 2005
	 	  	 16,666.6
	  	on the first day of each month commencing August 1, 2005 and ending July 1, 2007

  
 B. The Company
represents and warrants that it shall timely prepare and file with the Securities and Exchange Commission a registration statement on Form S-8 under the Securities Act of 1933 covering the sale of shares to Executive pursuant to the option grant and
any other documents as may be necessary to comply with the provisions of the Securities Act of 1933 and the Securities Exchange Act of 1934, each as amended, with respect to such plans and Executive’s grants and awards thereunder. 

 
 6. Executive Benefits. Executive shall be entitled to
participate in all benefit plans as shall be in effect for other executive officers of the Company from time to time, subject to the terms and conditions of each such plan. Executive shall be entitled to paid vacation each year in accordance with
the Company’s policies. 
  
 In addition, the Company shall pay up to Ten
Thousand and No/100 Dollars ($10,000) of Executive’s actual legal fees and costs incurred in connection with reviewing and negotiating the Agreement. 
  

 2 

 7. Expenses. Executive shall be reimbursed by the Company monthly for the ordinary and
necessary reasonable business expenses incurred by him in the performance of his duties for the Company, including travel and lodging expenses, meals, client entertainment, and cell phone expense, all in accordance with the Company’s policies;
provided that Executive shall first document said business expenses in the manner generally required by the Company under its policies and procedures. 
  
 8. Termination. 
  
 This Agreement shall terminate upon the occurrence of any of the following events: 
  
 A. Death of Executive; 
  
 B. Mental or physical disability of Executive which prevents him from performing substantially all of his duties hereunder for a period of 120 consecutive
days or 180 days during any one year. 
  
 C. For Cause, as defined
below: 
  
 (i) The Executive’s material breach of this
Agreement which is not cured within ten (10) days of receipt of written notice to Executive specifying the nature of such breach in reasonable detail; 
  
 (ii) The Executive’s dishonesty, fraud, malfeasance, gross negligence or misconduct which, in the reasonable judgment of the Board of Directors, is,
or is likely to, cause material injury to the Company or the business reputation of the Company; 
  
 (iii) The Executive’s willful failure to (a) follow the direction (consistent with the Executive’s duties) of the Board or (b) comply in all
material respects with the policies, procedures, and rules of the Company, as the same have been communicated to the Executive in writing which, in the case of either (a) or (b), is not cured within ten (10) days of receipt of written notice to the
Executive specifying the nature of such failure in reasonable detail; 
  
 (iv) Executive’s conviction of, or the Executive’s entry of a plea of guilty or no contest to, a felony or crime involving moral turpitude; or 
  
 (v) Executive’s resignation without Good Reason. 
  
 D. By either party in their sole discretion upon at least thirty (30) days’ prior written notice. 
  
 E. Without Cause. “Without Cause” means any termination of
employment by the Company which is not defined in sub-sections A, B, or C, above. 
  
 F. By Executive for Good Reason as defined below. 
  

 3 

 (i) For purposes of this Agreement “Good Reason” shall mean (1) the failure by the Company to
pay to the Executive the compensation or perform any other obligation due to him under this Agreement or any agreements evidencing the grant of the options described in Section 5 hereof; (2) the failure by the Company to allow the Executive to
participate in the Company’s employee benefit plans generally available from time to time to executives of the Company; (3) the failure of any successor to all or substantially all of the business and/or assets of the Company to assume this
Agreement; (4) relocation of the Executive to an office greater than twenty (20) miles from the current location without Executive’s consent; or (5) reduction of the Executive’s title, or material reduction of Executive’s duties or
responsibilities with the Company. 
  
 9. Post Termination
Payment Obligations. 
  
 A. If this Agreement terminates
for any of the reasons stated in sub-sections A, B or C of Section 8 of this Agreement or is terminated by Executive pursuant to subsection D of Section 8 of this Agreement, then the Executive shall be entitled to receive his Base Salary at the then
current rate and any accrued bonus through the effective date of the termination, payable within fifteen (15) days of the effective termination date, and thereafter the Company shall have no further obligations under this Agreement, but Executive
shall continue to be bound by Sections 12, 13, and 14 and all other post-termination obligations contained in this Agreement and provisions of this Agreement that specifically survive termination of this Agreement. 
  
 B. If this Agreement terminates in accordance with sub-sections E or F of
Section 8 of this Agreement or is terminated by the Company pursuant to subsection D of Section 8 of this Agreement then the Company shall pay Executive his Base Salary at the then current rate and any accrued bonus through the effective termination
date, payable within fifteen (15) days of the termination date and the Company shall pay Executive a separation payment in the amount of one year’s Base Salary at the then current rate (the “Separation Payment”). The Separation
Payment shall be paid in three installments as follows: 
  
 (i)
One-Third of the Separation Payment shall be payable upon the later of (a) fifteen (15) days after the termination date or (b) the day after the expiration date of Executive’s legally required right, if any, to revoke his signature or agreement
in connection with the Separation and Release Agreement described in Section 9(C) below; 
  
 (ii) One-Third of the Separation Payment shall be payable on the six (6) month anniversary of the termination date; and 
  
 (iii) One-Third of the Separation Payment shall be payable on the twelve (12) month anniversary of the termination date. 
  
 The post-termination obligations under this Section 9(B) shall be binding upon the Company
regardless of the Executive’s subsequent employment with any other person, 
  

 4 

 firm, partnership, association, business organization, corporation or other entity which is not affiliated with the
Company. 
  
 C. In consideration of, and as a condition to the
Company’s obligation to pay the Separation Payment, Executive shall: 
  
 (i) Execute a Separation and Release Agreement in a form prepared by and acceptable to the Company whereby Executive releases the Company from any and all liability and settles claims of any kind; and 
  
 (ii) Comply with the restrictive covenants (Sections 13 and 14 of this
Agreement), all other post-termination obligations contained in this Agreement and the provisions of this Agreement that specifically survive termination of this Agreement. 
  
 10. Work Product. All Work Product (defined below) shall be work made for hire by Executive and owned by the
Company. If any of the Work Product may not, by operation of law or otherwise, be considered work made for hire by Executive for the Company, or if ownership of all right, title, and interest to the legal rights therein shall not otherwise vest
exclusively in the Company, Executive hereby assigns to the Company, and upon the future creation thereof automatically assigns to the Company, without further consideration, the ownership of all Work Product. The Company shall have the right to
obtain and hold in its own name copyrights, patents, registrations, and any other protection available in the Work Product. Executive agrees to perform, during or after termination of Executive’s employment by the Company, such further acts as
may be necessary or desirable to transfer, perfect and defend the Company’s ownership of the Work Product as requested by the Company. “Work Product” means the data, materials, formulas, research, documentation, computer programs,
communication systems, audio systems, system designs, inventions (whether or not patentable), and all works of authorship, including all worldwide rights therein under patent, copyright, trade secret, confidential information, moral rights and other
property rights, created or developed in whole or in part by Executive, while employed by the Company, within the scope of Executive’s employment or which otherwise relates in any manner to the Company’s Business. 
  
 11. Set-Off. If at the time of termination of this Agreement
for any reason, Executive has any outstanding obligations to the Company, Executive acknowledges that the Company is authorized to deduct from Executive’s final paycheck and the Separation Payment any then documented amounts owed to the
Company. 
  
 12. No Mitigation; No Set-Off.
Executive shall have no obligation to seek other employment or take any other action to mitigate any amounts due to him under this Agreement. 
  
 13. Trade Secrets and Confidential Information. During the course of Executive’s employment with the Company, the Company may disclose
to Executive Trade Secrets and Confidential Information (defined below). The Trade Secrets and the Confidential Information of the Company are the sole and exclusive property of the Company (or a third party providing such information to the
Company). The disclosure of the Trade Secrets and the Confidential Information of the Company to Executive 
  

 5 

 does not give the Executive any license, interest or rights of any kind in the Trade Secrets or Confidential Information.

  
 A. Executive may use the Trade Secrets and Confidential
Information solely for the benefit of the Company while Executive is an employee of the Company. Executive shall hold in confidence the Trade Secrets and Confidential Information of the Company. Except in the performance of services for the Company,
Executive shall not reproduce, distribute, transmit, reverse engineer, decompile, disassemble, or transfer the Trade Secrets or the Confidential Information of the Company or any portion thereof. 
  
 B. The obligations under this Agreement with regard to the Trade Secrets of
the Company remain in effect as long as the information constitutes a trade secret under applicable law. The obligations with regard to the Confidential Information of the Company shall remain in effect while Executive is employed by the Company and
for a period of three (3) years thereafter. 
  
 C. Executive
agrees to return to the Company, upon Executive’s resignation, termination, or upon request by the Company, the Trade Secrets and Confidential Information of the Company and all materials relating thereto. 
  
 D. As used herein, “Trade Secrets” means information of the
Company, and its licensors, suppliers, clients and customers, including, but not limited to, technical or non-technical data, formulas, patterns, compilations, programs, devices, methods, techniques, drawings, processes, financial data, financial
plans, product plans, or a list of actual or potential customers or suppliers, which is not commonly known or available to the public and which information (i) derives economic value, actual or potential, from not being generally known to, and not
being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use and (ii) is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. 
  
 As used herein, “Confidential Information” means information, other than Trade
Secrets, that is treated as confidential, and that would potentially damage or interfere with, in any manner, the Company’s business if disclosed. Confidential Information includes, but is not limited to, information concerning the
Company’s financial structure, pricing, revenue sharing, partner agreements, customer agreements, marketing plans, methods of operation, and internal operating procedures. 
  
 Notwithstanding the foregoing, the provisions of this sub-section D do not apply to (i) information which is general knowledge in the
Company’s industry, (ii) information that has been disclosed to Executive by third parties who are unrelated to the Company and who are not bound by agreements of confidentiality with respect thereto, and (iii) as Executive may be required to
disclose by law but only to the extent required by law. 
  
 14.
Restrictive Covenants. 
  
 A. Non-competition.
Executive agrees that for so long as Executive is employed by the Company and for a period of one (1) year thereafter, Executive will 
  

 6 

 not, individually or on behalf of any person, firm, partnership, association, business organization, corporation or other
entity engaged in the Business of the Company, engage in or perform, anywhere within the United States, Canada and any other such geography in which the Company operates, which shall constitute the territory, any activities which are competitive
with the Business of the Company. Nothing herein shall be construed to prohibit Executive from acquiring shares of capital stock of any public corporation, provided that such investment does not exceed 5% of the stock of such public corporation.

  
 B. Non-Recruit. Executive agrees that for so long as
Executive is employed by the Company and for a period of one (1) year thereafter, Executive will not call upon, solicit, recruit, or assist others in calling upon, recruiting or soliciting any person who is an employee of the Company and with whom
Executive had contact or became aware of by virtue of Executive’s employment, for the purpose of having such person work for Executive or for any Client (as defined below) of the Company, or for any other person, firm, corporation or entity
which is engaged in the Business (defined below); provided, however, the restrictions set forth in this Section 14(B) shall not restrict Executive from calling upon, soliciting, recruiting or assisting others in calling upon, recruiting or
soliciting Bruce Zanca. 
  
 C. For purposes of this Section 13,
the term “Business” shall mean the business of the delivery of editorial content and product research related to consumer financial services delivered in print or over the Internet; and the term “Client” shall mean any individual
or business entity which employs the Company for purposes of delivery of editorial content and product research related to consumer financial services delivered in print or over the Internet. 
  
 15. Injunctive Relief. Executive acknowledges that breach of
the provisions of Sections 13, and/or 14 of this Agreement would result in irreparable injury and permanent damage to the Company, which prohibitions or restrictions Executive acknowledges are both reasonable and necessary under the circumstances,
singularly and in the aggregate, to protect the interests of the Company. Executive recognizes and agrees that the ascertainment of damages in the event of a breach of Sections 13 and/or 14 of this Agreement would be difficult, and that money
damages alone would be an inadequate remedy for the injuries and damages which would be suffered by the Company from breach by Executive. 
  
 Executive therefore agrees: (i) that, in the event of a breach of Sections 13 and/or 14 of this Agreement, the Company, in addition to and without limiting any of the
remedies or rights which it may have at law or in equity or pursuant to this Agreement, shall have the right to injunctive relief or other similar remedy in order to specifically enforce the provisions hereof; and (ii) to waive and not to (A) assert
any defense to the effect that the Company has an adequate remedy at law with respect to any such breach, (B) require that the Company submit proof of the economic value of any Trade Secret, or (C) require that the Company post a bond or any other
security. Nothing contained herein shall preclude the Company from seeking monetary damages of any kind, including reasonable fees and expenses of counsel and other expenses, in a court of law. 
  

 7 

 16. Survival. The provisions of Paragraphs 9 through 31 shall survive termination of this
Agreement. 
  
 17. Invalidity of Any Provision. It
is the intention of the parties hereto that Sections 12 through 14 of this Agreement shall be enforced to the fullest extent permissible under the laws and public policies of each state and jurisdiction in which such enforcement is sought, but that
the unenforceability (or the modification to conform with such laws or public policies) of any provision hereof shall not render unenforceable or impair the remainder of this Agreement which shall be deemed amended to delete or modify, as necessary,
the invalid or unenforceable provisions. The parties further agree to alter the balance of this Agreement in order to render the same valid and enforceable. 
  
 18. Waiver of Breach. The waiver by either party of a breach of any provision of this Agreement by the other shall not operate or be
construed as a waiver of any subsequent breach. 
  
 19.
Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the Company, its successors and assigns, and the Company shall require any successors and assigns to expressly assume and agree to perform this
Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession or assignment had taken place. Neither this Agreement nor any right or interest hereunder shall be assignable or transferable
by Executive, his beneficiaries or legal representatives, except by will or by the laws of descent and distribution. 
  
 20. License. To the extent that any pre-existing materials are contained in the materials Executive delivers to the Company or the
Company’s customers, and such preexisting materials are not Work Product, Executive grants to the Company an irrevocable, nonexclusive, worldwide, royalty-free license to: (i) use and distribute (internally or externally) copies of, and prepare
derivative works based upon, such pre-existing materials and derivative works thereof and (ii) authorize others to do any of the foregoing. Executive shall notify the Company in writing of any and all pre-existing materials delivered to the Company
by Executive. 
  
 21. Release. Executive
acknowledges that Executive may provide the image, likeness, voice, or other characteristics of Executive or third parties in the services, materials, computer programs and other deliverables that Executive provides as a part of this Agreement.
Executive hereby consents to the use of such characteristics of Executive by the Company in the products or services of the Company. 
  
 22. Severability. If any provision or part of a provision of this Agreement shall be determined to be void and unenforceable by a court of
competent jurisdiction, the remainder of this Agreement shall remain valid and enforceable. 
  
 23. No Prior Agreements. Executive hereby represents and warrants to the Company that the execution of this Agreement by Executive and Executive’s employment by the Company and the performance of
Executive’s duties hereunder 
  

 8 

 shall not violate or be a breach of any agreement with a former employer, client or any other person or entity.

  
 24. Entire Agreement. This Agreement represents
the entire understanding of the parties concerning the subject matter hereof and supersedes all prior communications, agreements and understandings, whether oral or written, relating to the subject matter hereof. The language contained herein shall
be deemed to be that negotiated and approved by both parties and no rule of strict construction shall be applied. 
  
 25. Modification. This Agreement may be modified only by agreement in writing signed by both the Company and Executive. 
  
 26. Governing Law. This Agreement shall be governed in all
aspects by the laws of the State of Florida without regard to its rules governing conflicts of law. 
  
 27. Section Headings. The section headings are included for convenience and are not intended to limit or affect the interpretation of this
Agreement. 
  
 28. Notice. Whenever any notice is
required, it shall be given in writing addressed as follows: 
  

					
	 To the Company:
	  	 Bankrate, Inc.
 11811 U.S. Highway One, Suite
101
 North Palm Beach, Fl 33408
 Attention: Peter
Morse
	  	 
			
	 With a copy to:
	  	 David G. Bates, Esq.
 Gunster, Yoakley &
Stewart, P.A.
 777 South Flagler Drive, Suite 500-East
 West Palm
Beach, FL 33401
	  	 
			
	 To Executive:
	  	 Thomas R. Evans
 350 East 79th Street,
#35C
 New York, NY 10021
	  	 
			
	 With a copy to:
	  	 William J. Grant, Jr., Esq.
 Willkie Farr &
Gallagher
 787 Seventh Avenue
 New York, NY 10019
	  	 

  
 Notice shall be deemed given and
effective three (3) days after the deposit in the U.S. mail of a writing addressed as above and sent first class mail, certified, return receipt requested, or when actually received. Either party may change the address for notice by notifying the
other party of such change in accordance with this Section. 
  
 29. Indemnification. The Company agrees, to the greatest extent permitted by applicable law and the Company’s Articles of Incorporation, to defend, indemnify and hold harmless Executive against any and all loss, damage,
liability and expense, 
  

 9 

 including, without limitation, reasonable attorneys’ fees, disbursements court costs, and any amounts paid in
settlement and the costs and expenses of enforcing this section of the Agreement, which may be suffered or incurred by Executive in connection with the provision of his services hereunder, including, without limitation, any claims, litigations,
disputes, actions, investigations or other matters, provided that such loss, damage, liability and expense (i) arises out of or in connection with the performance by Executive of his obligations under this Agreement and (ii) is not the result of any
material breach by Executive of his obligations hereunder, and provided further that the Company shall be under no obligation to defend, indemnify or hold harmless Executive if Executive has acted with gross negligence or willful misconduct.

  
 In addition to the foregoing, the Company agrees to provide Executive with
coverage under a Directors & Officers insurance policy to the same extent as the Company currently provides its executive officers. 
  
 30. Jurisdiction and Venue. The parties acknowledge that a substantial portion of the negotiations, anticipated performance and execution of
this Agreement occurred or shall occur in Palm Beach County, Florida. Any civil action or legal proceeding arising out of or relating to this Agreement shall be brought in the courts of record of the State of Florida in Palm Beach County or the
United States District Court, Southern District of Florida. Each party consents to the jurisdiction of such Florida court in any such civil action or legal proceeding and waives any objection to the laying of venue of any such civil action or legal
proceeding in such Florida court. Service of any court paper may be effected on such party by mail, as provided in this Agreement, or in such other manner as may be provided under applicable laws, rules of procedure or local rules. 
  
 31. JURY WAIVER. IN ANY CIVIL ACTION, COUNTERCLAIM, OR
PROCEEDING, WHETHER AT LAW OR IN EQUITY, WHICH ARISES OUT OF, CONCERNS, OR RELATES TO THIS AGREEMENT, ANY AND ALL TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE PERFORMANCE OF THIS AGREEMENT, OR THE RELATIONSHIP CREATED BY THIS AGREEMENT, WHETHER
SOUNDING IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE, TRIAL SHALL BE TO A COURT OF COMPETENT JURISDICTION AND NOT TO A JURY. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY. ANY PARTY MAY FILE AN ORIGINAL
COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT, AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THIS AGREEMENT OF THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. NEITHER PARTY HAS MADE OR RELIED UPON ANY ORAL REPRESENTATIONS TO OR BY ANY
OTHER PARTY REGARDING THE ENFORCEABILITY OF THIS PROVISION. EACH PARTY HAS READ AND UNDERSTANDS THE EFFECT OF THIS JURY WAIVER PROVISION. EACH PARTY ACKNOWLEDGES THAT IT HAS BEEN ADVISED BY ITS OWN COUNSEL WITH RESPECT TO THE TRANSACTION GOVERNED BY
THIS AGREEMENT AND SPECIFICALLY WITH RESPECT TO THE TERMS OF THIS SECTION. IN CONNECTION WITH ANY PROCEEDING BROUGHT PURSUANT TO THIS SECTION 31, EACH PARTY SHALL BEAR ITS OWN COSTS AND EXPENSES, INCLUDING ATTORNEY’S FEES, AND NEITHER PARTY
SHALL BE ENTITLED TO RECOVER 
  

 10 

 SUCH COSTS OR EXPENSES EXPENDED IN THE COURSE OF SUCH PROCEEDING. 
  
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the day and year first above written. 
  

							
	EXECUTIVE: 	 	 	 	 COMPANY:
 BANKRATE,
INC.

				
	/s/ Thomas R. Evans	 	 	 	By: /s/	 	Robert J. DeFranco
	     Thomas R. Evans	 	 	 	 	 	 Robert J. DeFranco
 Senior Vice President

Chief Financial Officer

  

 11 

 ADDENDUM A 
  
 Mr. Evans will continue to serve on the Board of Directors of Navisite.Amended and Restated 1993 Director Stock Option Plan

 Exhibit 10.3 
  
 DSP GROUP, INC. 
  
 1993 DIRECTOR STOCK OPTION PLAN 
 (Amended and
Restated July 19, 1999) 
 (Amended and Restated July 18, 2001) 
 (Amended and Restated April 4, 2002) 
 (Amended and Restated November 25, 2002) 
 (Amended and Restated January 22, 2003) 
 (Amended and Restated March 12, 2003) 
 (Amended and Restated May 5, 2004) 
  
 1. Purposes of the Plan. The purposes of this Director Stock Option
Plan are to attract and retain the best available personnel for service as Directors of the Company, to provide additional incentive to the Outside Directors of the Company to serve as Directors, and to encourage their continued service on the
Board. 
  
 All options granted hereunder shall be
“nonstatutory stock options.” 
  
 2. Definitions.
As used herein, the following definitions shall apply: 
  
 a.
“Board” shall mean the Board of Directors of the Company. 
  
 b. “Code” shall mean the Internal Revenue Code of 1986, as amended. 
  
 c. “Common Stock” shall mean the Common Stock of the Company. 
  
 d. “Company” shall mean DSP Group, Inc., a Delaware corporation. 
  
 e. “Continuous Status as a Director” shall mean the absence
of any interruption or termination of service as a Director. 
  
 f. “Director” shall mean a member of the Board or the board of directors of ParthusCeva, Inc. 
  
 g. “Effective Date” shall have the meaning as set forth in Section 6 below. 
  
 h. “Employee” shall mean any person, including officers and Directors, employed by the Company,
ParthusCeva, Inc. or any Parent or Subsidiary of either company. The payment of a Director’s fee by the Company, ParthusCeva, Inc. or any Parent or Subsidiary of either company shall not be sufficient in and of itself to constitute
“employment” by the Company. 
  
 i. “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended. 
  
 j. “First Option” shall have the meaning as set forth in Section 4.b.ii. below. 
  
 k. “Option” shall mean a stock option granted pursuant to the Plan. 
  
 l. “Optioned Stock” shall mean the Common Stock subject to an Option. 
  
 m. “Optionee” shall mean an Outside Director who receives an
Option. 
  
 n. “Outside Director” shall mean a
Director who is not an Employee. 
  
 o. “Parent”
shall mean a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code. 
  
 p. “Plan” shall mean this 1993 Director Stock Option Plan. 
  
 q. “Share” shall mean a share of the Common Stock, as adjusted in accordance with Section 11 of the Plan.

  
 r. “Spin-off Transaction” means a
distribution by the Company to its stockholders of all or any portion of the securities of any Subsidiary of the Company. 

 s. “Subsequent Option” shall have the meaning as set forth in Section 4.b.iii. below.

  
 t. “Subsidiary” shall mean a “Subsidiary
Corporation,” whether now or hereafter existing, as defined in Section 424(f) of the Code. 
  
 u. “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 126-2 promulgated under
the Exchange Act. 
  
 v. “Change in Control”
means a change in ownership or control of the Company effected through either of the following transactions: 
  
 (i) the direct or indirect acquisition by any person or related group of persons (other than an acquisition from or by the Company or by a
Company-sponsored employee benefit plan or by a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities
possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities pursuant to a tender or exchange offer made directly to the Company’s stockholders which a majority of the Continuing
Directors who are not Affiliates or Associates of the offeror do not recommend such stockholders accept, or 
  
 (ii) a change in the composition of the Board over a period of thirty-six (36) months or less such that a majority of the Board members
(rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who are Continuing Directors. 
  
 w. “Continuing Directors” means members of the Board who either (i) have been Board members continuously
for a period of at least thirty-six (36) months or (ii) have been Board members for less than thirty-six (36) months and were elected or nominated for election as Board members by at least a majority of the Board members described in clause (i) who
were still in office at the time such election or nomination was approved by the Board. 
  
 x. “Corporate Transaction” means any of the following stockholder-approved transactions to which the Company is a party: 
  
 (i) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the
principal purpose of which is to change the state in which the Company is incorporated; 
  
 (ii) the sale, transfer or other disposition of all or substantially all of the assets of the Company (including the capital stock of the
Company’s subsidiary corporations) in connection with the complete liquidation or dissolution of the Company; or 
  
 (iii) any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent (50%) of
the total combined voting power of the Company’s outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger. 
  
 3. Stock Subject to the Plan. Subject to the provisions of Section 11
of the Plan, as of June 1, 2003 the maximum aggregate number of Shares which may be optioned and sold under the Plan is 1,130,875 Shares (the “Pool”) of Common Stock. The Shares may be authorized, but unissued, or reacquired Common Stock.

  
 Initially, 175,000 Shares were reserved for issuance under the
Plan. In June 1999, the Plan was amended and restated to increase the number of Shares reserved for issuance under the Plan by 100,000 shares for a total reserve of 275,000 Shares. In March 2000, the Company effected a two-for-one split of the
Company’s common stock thereby increasing the number of Shares reserved for issuance under the Plan to 550,000 Shares. In June 2002, the Plan was amended and restated to increase the number of Shares reserved for issuance under the Plan by
200,000 Shares for a total reserve of 750,000 Shares. As a result of the Company’s distribution of all (or substantially all) of the shares of capital stock of Ceva, Inc. in November 2002, the 

  

 2 

 
number of shares reserved for issuance under the Plan was adjusted so that 890,875 Shares are available for issuance under the Plan. In January 2003, the
Plan was again amended and restated to increase the number of Shares reserved for issuance under the Plan by 240,000 Shares for a total reserve of 1,130,875 Shares. 
  
 If an Option should expire or become unexercisable for any reason without having been exercised in full, the unpurchased
Shares which were subject thereto shall, unless the Plan shall have been terminated, become available for future grant under the Plan. If Shares which were acquired upon exercise of an Option are subsequently repurchased by the Company, such Shares
shall not in any event be returned to the Plan and shall not become available for future grant under the Plan. 
  
 4. Administration of and Grants of Options under the Plan. 
  
 a. Administrator. Except as otherwise required herein, the Plan shall be administered by the Board. 
  
 b. Procedure for Grants. All grants of Options hereunder shall be
automatic and nondiscretionary and shall be made strictly in accordance with the following provisions: 
  
 i) No person shall have any discretion to select which Outside Directors of the Company shall be granted Options or to determine the number of Shares to
be covered by Options granted to Outside Directors of the Company. 
  
 ii) Each person who is an Outside Director of the Company on the Effective Date of this Plan shall be automatically granted an Option to purchase 30,000 Shares (the “First Option”) on the Effective Date of this Plan, as determined
in accordance with Section 6 hereof. Each Outside Director who becomes a member of the Board after the Effective Date but prior to January 21, 2003 shall be automatically granted an Option to purchase 30,000 Shares (also a “First Option”)
on the date on which such person first becomes an Outside Director of the Company, whether through election by the stockholders of the Company or appointment by the Board to fill a vacancy. Each Outside Director who becomes a member of the Board
after January 21, 2003 shall be automatically granted an Option to purchase 60,000 Shares (also a “First Option”) on the date on which such person first becomes an Outside Director of the Company, whether through election by the
stockholders of the Company or appointment by the Board to fill a vacancy. Each Outside Director who becomes a member of the Board after May 5, 2004 shall be shall be automatically granted an Option to purchase 30,000 Shares (also a “First
Option”) on the date on which such person first becomes an Outside Director of the Company, whether through election by the stockholders of the Company or appointment by the Board to fill a vacancy. 
  
 iii) From January 1, 1997 through December 31, 2003, each Outside Director
of the Company shall be automatically granted (i) an Option to purchase 10,000 Shares (a “Subsequent Option”), on January 1 of each year, if on such date, he or she shall have served on the Board for at least six (6) months and (ii) an
Option to purchase 10,000 Shares (a “Committee Option”), on January 1 of each year, for each committee of the Board on which he or she shall have served as the chairperson for at least six (6) months on such date. From January 1, 2004 to
December 31, 2004, each Outside Director of the Company shall be automatically granted (i) an Option to purchase 20,000 Shares (also a “Subsequent Option”), on January 1 of each year, if on such date, he or she shall have served on the
Board for at least six (6) months and (ii) an Option to purchase 20,000 Shares (also a “Committee Option”), on January 1 of each year, for each committee of the Board on which he or she shall have served as the chairperson for at least six
(6) months on such date. Beginning on January 1, 2005, each Outside Director of the Company shall be automatically granted (i) an Option to purchase 15,000 Shares (also a “Subsequent Option”), on January 1 of each year, if on such date, he
or she shall have served on the Board for at least six (6) months and (ii) an Option to purchase 15,000 Shares (also a “Committee Option”), on January 1 of each year, for each committee of the Board on which he or she shall have served as
the chairperson for at least six (6) months on such date. 
  
 iv)
Notwithstanding the provisions of subsections ii) and iii) hereof, in the event that a grant would cause the number of Shares subject to outstanding Options, plus the number of shares previously purchased upon exercise of Options to exceed the Pool,
then each such automatic grant shall be for that number of Shares determined by dividing the total number of Shares remaining available for grant by the number of grants to be made on the automatic grant date. Any further grants shall then be
deferred until such time, if any, as additional Shares become available for grant under the Plan through action of the stockholders to increase the number of Shares which may be issued under the Plan or through cancellation or expiration of Options
previously granted hereunder. 
  

 3 

 v) Notwithstanding the provisions of subsections ii) and iii) hereof, any grant of an Option made before
the Company has obtained stockholder approval of the Plan in accordance with Section 17 hereof shall have their exercisability conditioned upon obtaining such stockholder approval of the Plan in accordance with Section 17 hereof. 
  
 vi) The terms of any Option granted hereunder shall be as follows:

  
 a) The Option shall be exercisable only while the Outside
Director remains a Director of the Company or ParthusCeva, Inc., except as set forth in Section 9 hereof. 
  
 b) The exercise price per Share shall be 100% of the fair market value (as defined in Section 8.b. hereunder) per Share on the date of grant of the
Option. 
  
 c) The Option shall vest and become exercisable as to
one-third of the Shares subject to the Option on the first anniversary of the date of grant of the Option, and shall vest and become exercisable as to one-third of the Shares subject to the Option at the end of each twelve-month period thereafter,
subject to the provisions set forth in Section 9, below. 
  
 d)
The Board may accelerate the unvested portion of any Option granted under the Plan held by any Director whose Continuous Status as Director terminates for any reason prior to the Option being fully exercisable. 
  
 c. Powers of the Board. Subject to the provisions and restrictions of
the Plan, the Board shall have the authority, in its discretion: (i) to determine, upon review of relevant information and in accordance with Section 8.b. of the Plan, the fair market value of the Common Stock; (ii) to determine the exercise price
per share of Options to be granted, which exercise price shall be determined in accordance with Section 8.a. of the Plan; (iii) to interpret the Plan; (iv) to prescribe, amend and rescind rules and regulations relating to the Plan; (v) to authorize
any person to execute on behalf of the Company any instrument required to effectuate the grant of an Option previously granted hereunder; and (vi) to make all other determinations deemed necessary or advisable for the administration of the Plan.

  
 d. Effect of Board’s Decision. All decisions,
determinations and interpretations of the Board shall be final and binding on all Optionees and any other holders of any Options granted under the Plan. 
  
 5. Eligibility. Options may be granted only to Outside Directors of the Company. All Options shall be automatically granted in accordance with the
terms set forth in Section 4.b. hereof. An Outside Director who has been granted an Option may, if he or she is otherwise eligible, be granted an additional Option or Options in accordance with such provisions. 
  
 The Plan shall not confer upon an Optionee any right with respect to
continuation of service as a Director or nomination to serve as a Director, nor shall it interfere in any way with any rights which the Director or the Company may have to terminate his or her directorship at any time. 
  
 6. Term of Plan; Effective Date. The Plan shall become effective on
the date on which the Company’s registration statement on Form S-1 (or any successor form thereof) is declared effective by the Securities and Exchange Commission (the “Effective Date”). It shall continue in effect for a term of
twenty (20) years, unless sooner terminated under Section 13 of the Plan, subject to the limitations set forth in this Plan. 
  
 7. Term of Option. The term of each Option shall be ten (10) years from the date of grant thereof. 
  
 8. Exercise Price and Consideration. 
  
 a. Exercise Price. The per Share exercise price for the Shares to be
issued pursuant to exercise of an Option shall be 100% of the fair market value per Share on the date of grant of the Option. 
  
 b. Fair Market Value. The fair market value per Share shall be the mean of the bid and asked prices of the Common Stock in the over-the-counter
market on the date of grant, as reported in The Wall Street Journal (or, if not so reported, as otherwise reported by the National Association of Securities Dealers Automated Quotation (“NASDAQ”) System) or, in the event that the
Common Stock is traded on the NASDAQ 

  

 4 

 
National Market System or listed on a stock exchange, the fair market value per Share shall be the closing price on such system or exchange on the date of
grant of the Option, as reported in The Wall Street Journal; provided, however, that if such market or exchange is closed on the date of the grant of the Option then the fair market value per Share shall be based on the most recent date on
which such trading occurred immediately prior to the date of the grant of the Option; provided, further, that for purposes of First Options granted on the Effective Date, the fair market value per share shall be the initial public offering price as
set forth in the final prospectus filed with the Securities and Exchange Commission pursuant to Rule 424 under the Securities Act of 1933, as amended. 
  
 c. Form of Consideration. The consideration to be paid for the Share to be issued upon exercise of an Option shall consist entirely of cash, check,
other Shares having a fair market value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised (which, if acquired from the Company, shall have been held for at least six months),
delivery of a properly executed exercise notice, together with such other documentation as the Company and the broker, if applicable, shall require to effect an exercise of the Option and delivery to the Company of the funds required to pay the
exercise price, or any combination of such methods of payment and/or any other consideration or method of payment as shall be permitted under applicable corporate law. 
  
 9. Exercise of Option. 
  
 a. Procedure for Exercise: Rights as a Stockholder. An Option granted hereunder shall be exercisable at such times as are set forth in Section 4.b.
hereof; provided, however, that no Options shall be exercisable until stockholder approval of the Plan in accordance with Section 17 hereof has been obtained. 
  

An option may not be exercised for a fraction of a Share. 
  
 An Option shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms of the Option by
the person entitled to exercise the Option and full payment for the Shares with respect to which the Option is exercised has been received by the Company. Full payment may consist of any consideration and method of payment allowable under Section
8.c. of the Plan. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate evidencing such Shares, no right to vote or receive dividends or
any other rights as a stockholder shall exist with respect to the Optioned Stock, notwithstanding the exercise of the Option. A share certificate for the number of Shares so acquired shall be issued to the Optionee as soon as practicable after
exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 11 of the Plan. 
  
 Exercise of an Option in any manner shall result in a decrease in the number
of Shares which thereafter may be available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. 
  
 b. Termination of Status as a Director. If an Outside Director ceases to serve as a Director, he or she may, but only
within three (3) months after the date he or she ceases to be a Director, exercise his or her Option to the extent that he or she was entitled to exercise it at the date of such termination Option’s expiration date. Notwithstanding the
foregoing, in no event may the Option be exercised after its term set forth in Section 7 has expired. The Board may extend the exercise period of an Option held by a Director whose term is expiring to any date prior to the Option’s expiration
date. To the extent that such Outside Director was not entitled to exercise an Option at the date of such termination, or does not exercise such Option (which he or she was entitled to exercise) within the time specified herein, the Option shall
terminate. 
  
 c. Disability of Optionee. Notwithstanding
the provisions of Section 9.b. above, in the event a Director is unable to continue his or her service as a Director as a result of his or her total and permanent disability (as defined in Section 22(e)(3) of the Internal Revenue Code), he or she
may, but only within six (6) months from the date of such termination, exercise his or her Option to the extent he or she was entitled to exercise it at the date of such termination. The Board may extend the exercise period of an Option held by a
Director whose Continuous Status as Director terminates as a result of his or her total and permanent disability. Notwithstanding the foregoing, in no event may the Option be exercised after its term set forth in Section 7 has expired. To the extent
that he or she was not entitled to exercise the Option at the date of termination, or if he or she does not exercise such Option (which he or she was entitled to exercise) within the time specified herein, the Option shall terminate. 
  

 5 

 d. Death of Optionee. In the event of the death of an Optionee: 
  
 i) during the term of the Option who is, at the time of his or her death, a
Director and who shall have been in Continuous Status as a Director since the date of grant of the Option, the Option may be exercised, at any time within twelve (12) months following the date of death, by the Optionee’s estate or by a person
who acquired the right to exercise the Option by bequest or inheritance, but only to the extent of the right to exercise that would have accrued had the Optionee continued living and remained in Continuous Status as Director for six (6) months after
the date of death. The Board may extend the exercise period of an Option held by a Director whose Continuous Status as Director terminates as a result of his or her death. Notwithstanding the foregoing, in no event may the Option be exercised after
its term set forth in Section 7 has expired. 
  
 ii) within three
(3) months after the termination of Continuous Status as a Director, the Option may be exercised, at any time within twelve (12) months following the date of death, by the Optionee’s estate or by a person who acquired the right to exercise the
Option by bequest or inheritance, but only to the extent of the right to exercise that had accrued at the date of termination. The Board may extend the exercise period of an Option held by a Director who dies within three (3) months after the
termination of Continuous Status as a Director. Notwithstanding the foregoing, in no event may the option be exercised after its term set forth in Section 7 has expired. 
  
 10. Nontransferability of Options. The Option may not be sold, pledged, assigned, hypothecated, transferred, or
disposed of in any manner other than by will or by the laws of descent or distribution. The designation of a beneficiary by an Optionee does not constitute a transfer. An Option may be exercised during the lifetime of an Optionee only by the
Optionee or a transferee permitted under this Section. 
  
 11.
Adjustments Upon Changes in Capitalization, Dissolution, Merger or Asset Sale. 
  
 a. Changes in Capitalization. Subject to any required action by the stockholders of the Company, the number of Shares covered by each outstanding Option and the number of Shares which have been authorized for
issuance under the Plan but as to which no Options have yet been granted or which have been returned to the Plan upon cancellation or expiration of an Option, as well as the price per Share covered by each such outstanding Option, shall be
proportionately adjusted for an increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the
number of issued shares effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.”
Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into
shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or prices of Shares subject to an Option. Notwithstanding any terms of the Plan to the contrary, in the event of a Spin-off
Transaction, the Board may in its discretion and without stockholder approval make such adjustments and take such other action as it deems appropriate with respect to outstanding Options under the Plan, including but not limited to adjustments to
the number and kind of shares, the price per share and the vesting periods of outstanding Options or the substitution, exchange or grant of Options to purchase securities of the Subsidiary; provided that the Board shall not be obligated to make any
such adjustments or take any such action hereunder. 
  
 b.
Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, to the extent that an Option has not been previously exercised, it will terminate immediately prior to the consummation of such proposed
action. The Board may, in the exercise of its sole discretion in such instances, declare that any Option shall terminate as of a date fixed by the Board and give each Optionee the right to exercise his or her Option as to all or any part of the
Optioned Stock, including Shares as to which the Option would not otherwise be exercisable. 
  
 c. Merger or Asset Sale. In the event of a Corporate Transaction, each Option which is at the time outstanding under the Plan automatically shall become fully vested and exercisable and be released from any
restrictions on transfer and repurchase or forfeiture rights, immediately prior to the specified effective 

  

 6 

 
date of such Corporate Transaction, for all of the Shares at the time represented by such Option. Effective upon the consummation of the Corporate
Transaction, all outstanding Options under the Plan shall terminate unless assumed by the successor company or its Parent. In the event of a Change in Control (other than a Change in Control which also is a Corporate Transaction), each Option which
is at the time outstanding under the Plan automatically shall become fully vested and exercisable and be released from any restrictions on transfer and repurchase or forfeiture rights, immediately prior to the specified effective date of such Change
in Control, for all of the Shares at the time represented by such Options. Each such Option shall remain exercisable until the expiration or sooner termination of the applicable Option term. 
  
 12. Time of Granting Options. The date of grant of an Option shall,
for all purposes, be the date determined in accordance with Section 4.b. hereof. Notice of the determination shall be given to each Outside Director to whom an Option is so granted within a reasonable time after the date of such grant. 

 
 13. Amendment and Termination of the Plan. 
  
 a. Amendment and Termination. The Board may amend or terminate the
Plan from time to time in such respects as the Board may deem advisable; provided that, to the extent necessary and desirable to comply with Rule 16b-3 under the Exchange Act (or any other applicable law or regulation), the Company shall obtain
approval of the stockholders of the Company to Plan amendments to the extent and in the manner required by such law or regulation. In addition, the approval of the stockholders is required for any Plan amendment which would permit decreasing the
exercise price of any Option outstanding under the Plan, subject to Section 11(a). Further, the approval of the Company’s stockholders is required for any Plan amendment which would change any of the provisions of this Section 13(a). For
purposes of this Section, approval of the stockholders means, except as provided by Applicable Law, approval by the holders of a majority of the Shares of Common Stock of the Company present or represented by proxy (and entitled to vote) at a
meeting of the Company’s stockholders. 
  
 b. Effect of
Amendment or Termination. Any such amendment or termination of the Plan that would impair the rights of any Optionee shall not affect Options already granted to such Optionee and such Options shall remain in full force and effect as if this Plan
had not been amended or terminated, unless mutually agreed otherwise between the Optionee and the Board, which agreement must be in writing and signed by the Optionee and the Company. 
  
 14. Conditions Upon Issuance of Shares. Shares shall not be issued pursuant to the exercise of an Option unless the
exercise of such Option and the issuance and delivery of such Shares pursuant thereto shall comply with all relevant provisions of law, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act, the rules and
regulations promulgated thereunder, state securities laws, and the requirements of any stock exchange upon which the Shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance.

  
 As a condition to the exercise of an Option, the Company may
require the person exercising such Option to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares, if, in the opinion of
counsel for the Company, such a representation is required by any of the aforementioned relevant provisions of law. 
  
 Inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be
necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained. 
  
 15. Reservation of Shares. The Company, during the term of this Plan,
will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan. 
  
 16. Option Agreement. Options shall be evidenced by written option agreements in such form as the Board shall approve. 
  
 17. Plan Approval. The Plan was adopted by the Board on November 29,
1993 and adopted by the stockholders of the Company in January 10, 1994. The Plan was subsequently amended and restated, as approved by the Company’s stockholders in May 1996. In June 1999, the Board adopted and approved an amendment and
restatement of the Plan to increase the number of shares of common stock reserved for issuance under the Plan, which amendment was approved by the Company’s stockholders. In July 2001, the Board 

  

 7 

 
adopted and approved an amendment and restatement of the Plan to amend various terms of the Plan in anticipation of the distribution of all (or substantially
all) of the shares of capital stock of Ceva, Inc., a Delaware corporation and a wholly-owned subsidiary, held by the Company to the stockholders of the Company. In April 2002, the Board adopted and approved an amendment and restatement of the Plan
to increase the number of shares of common stock reserved for issuance under the Plan and the term of the Plan, which amendments were approved by the Company’s stockholders. In November 2002, the Board adopted and approved an amendment and
restatement of the Plan to include an appendix to the Plan designed to comply with changes in Israeli tax law effective January 1, 2003, which amendment did not require approval by the Company’s stockholders. Subject to stockholder approval,
the Board further adopted and approved in January 2003 an amendment and restatement of the Plan to (a) increase the number of shares of Common Stock reserved for issuance under the Plan, (b) increase the number of shares subject to each First
Option, Subsequent Option and Committee Option (which increases shall be effective on a prospective basis) and (c) amend certain other administrative terms of the Plan. In March 2003, the Board adopted and approved an amendment and restatement of
the Plan to amend the appendix to the Plan in order to comply with further changes in Israeli tax law which amendment did not require approval by the Company’s stockholders. In May 2004, the Board adopted and approved an amendment and
restatement of the Plan to decrease the number of shares subject to each First Option, Subsequent Option and Committee Option on a prospective basis, which amendment did not require approval by the Company’s stockholders. 
  

 8 

 DSP GROUP, INC. 1993 DIRECTOR STOCK OPTION PLAN 
  
 APPENDIX A - ISRAEL 
  

	1.	GENERAL 

  

	 	1.1	This appendix (the “Appendix”) shall apply only to Grantees who are residents of the state of Israel or those who are deemed to be residents of the state of Israel
for the payment of tax. The provisions specified hereunder shall form an integral part of the 1993 Director Stock Option Plan (hereinafter: the “Plan”), which applies to the issuance of options to purchase Common Stock of DSP Group
Inc. (hereinafter: the “Company”). 

  

	 	1.2	This Appendix is effective with respect to Options granted as of January 1, 2003 and shall comply with Amendment no. 132 of the Israeli Tax Ordinance. 

  

	 	1.3	This Appendix is to be read as a continuation of the Plan and only modifies Options granted to Israeli Grantees so that they comply with the requirements set by the Israeli law in
general, and in particular with the provisions of Section 102 (as specified herein), as may be amended or replaced from time to time. For the avoidance of doubt, this Appendix does not add to or modify the Plan in respect of any other category of
Grantees. 

  

	 	1.4	The Plan and this Appendix are complimentary to each other and shall be deemed as one. In any case of contradiction, whether explicit or implied, between the provisions of this
Appendix and the Plan, the provisions set out in the Appendix shall prevail. 

  

	 	1.5	Any capitalized term not specifically defined in this Appendix shall be construed according to the defined meaning given to it in the Plan. 

  

	2.	DEFINITIONS 

  

	 	2.1	“Affiliate” means any “employing company” within the meaning of Section 102(a) of the Ordinance. 

  

	 	2.2	“Approved 102 Option” means an Option granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Grantee.

  

	 	2.3	“Capital Gain Option (CGO)” means an Approved 102 Option elected and designated by the Company to qualify under the capital gain tax treatment in accordance with
the provisions of Section 102(b)(2) of the Ordinance. 

  

	 	2.4	“Controlling Stockholder” shall have the meaning ascribed to it in Section 32(9) of the Ordinance. 

  

	 	2.5	“Director” means a member of the Board, but excluding any Controlling Stockholder. 

  

	 	2.6	“ITA” means the Israeli Tax Authorities. 

  

	 	2.7	“Ordinary Income Option (OIO)” means an Approved 102 Option elected and designated by the Company to qualify under the ordinary income tax treatment in accordance
with the provisions of Section 102(b)(1) of the Ordinance. 

  

 - A1 

	 	2.8	“Option” means an option to purchase one or more shares of Common Stock of the Company pursuant to the Plan. 

  

	 	2.9	“102 Option” means any Option granted to Directors pursuant to Section 102 of the Ordinance. 

  

	 	2.10	“3(i) Option” means an Option granted pursuant to Section 3(i) of the Ordinance to any person who is a Non-Employee. 

  

	 	2.11	“Ordinance” means the 1961 Israeli Income Tax Ordinance [New Version] 1961 as now in effect or as hereafter amended. 

  

	 	2.12	“Section 102” means section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now in effect or as hereafter amended.

  

	 	2.13	“Trustee” means any individual appointed by the Company to serve as a trustee and approved by the ITA, all in accordance with the provisions of Section 102(a) of
the Ordinance. 

  

	 	2.14	“Unapproved 102 Option” means an Option granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee. 

  

	3.	ISSUANCE OF OPTIONS 

  

	 	3.1	The persons eligible for participation in the Plan as Grantees shall be Directors of the Company or of any Affiliate; provided, however, that (i) Directors who are not Controlling
Stockholders may only be granted 102 Options; and (ii) Directors who are Controlling Stockholders may only be granted 3(i) Options. 

  

	 	3.2	The Company may designate Options granted to Directors pursuant to Section 102 as Unapproved 102 Options or Approved 102 Options. 

  

	 	3.3	The grant of Approved 102 Options shall be made under this Appendix adopted by the Board, and shall be conditioned upon the approval of this Appendix by the ITA.

  

	 	3.4	Approved 102 Options may either be classified as Capital Gain Options (“CGOs”) or Ordinary Income Options (“OIOs”). 

  

	 	3.5	No Approved 102 Options may be granted under this Appendix to any eligible Director, unless and until, the Company’s election of the type of Approved 102 Options as CGI or OIO
granted to Directors (the “Election”), is appropriately filed with the ITA. Such Election shall become effective beginning the first grant date of an Approved 102 Option under this Appendix and shall remain in effect until the end
of the year following the year during which the Company first granted Approved 102 Options. The Election shall obligate the Company to grant only the type of Approved 102 Option it has elected, and shall apply to all Grantees who were granted
Approved 102 Options during the period indicated herein, all in accordance with the provisions of Section 102(g) of the Ordinance. For the avoidance of doubt, such Election shall not prevent the Company from granting Unapproved 102 Options
simultaneously. 

  

	 	3.6	All Approved 102 Options must be held in trust by a Trustee, as described in Section 4 below. 

  

 - A2 

	 	3.7	For the avoidance of doubt, the designation of Unapproved 102 Options and Approved 102 Options shall be subject to the terms and conditions set forth in Section 102.

  

	 	3.8	With respect to Unapproved 102 Option, if the Optionee ceases to be employed by the Company or any Affiliate, the Optionee shall extend to the Company and/or its Affiliate a
security or guarantee for the payment of tax due at the time of sale of Shares, all in accordance with the provisions of Section 102 and the rules, regulation or orders promulgated thereunder. 

  

	4.	TRUSTEE 

  

	 	4.1	Approved 102 Options which shall be granted under this Appendix and/or any Common Stock allocated or issued upon exercise of such Approved 102 Options and/or other Common Stock
received subsequently following any realization of rights, including bonus shares, shall be allocated or issued to the Trustee and held for the benefit of the Grantees for such period of time as required by Section 102 or any regulations, rules or
orders or procedures promulgated thereunder (the “Holding Period”). In the case the requirements for Approved 102 Options are not met, then the Approved 102 Options shall be regarded as Unapproved 102 Options, all in accordance with
the provisions of Section 102. 

  

	 	4.2	Notwithstanding anything to the contrary, the Trustee shall not release any Common Stock allocated or issued upon exercise of Approved 102 Options prior to the full payment of the
Grantee ‘s tax liabilities arising from Approved 102 Options which were granted to him and/or any Common Stock allocated or issued upon exercise of such Options. 

  

	 	4.3	Upon receipt of Approved 102 Options, the Grantee will sign an undertaking to release the Trustee from any liability in respect of any action or decision duly taken and bona fide
executed in relation with this Appendix, or any Approved 102 Option or Common Stock granted to him thereunder. 

  

	 	4.4	With respect to any Approved 102 Option, subject to the provisions of Section 102 and any rules or regulation or orders or procedures promulgated thereunder, an Optionee shall not
sell or release from trust any Share received upon the exercise of an Approved 102 Option and/or any share received subsequently following any realization of rights, including without limitation, bonus shares, until the lapse of the Holding Period
required under Section 102 of the Ordinance. Notwithstanding the above, if any such sale or release occurs during the Holding Period, the sanctions under Section 102 of the Ordinance and under any rules or regulation or orders or procedures
promulgated thereunder shall apply to and shall be borne by such Optionee. 

  

	5.	THE OPTIONS 

  
 The terms and conditions upon which the Options shall be issued and exercised, shall be as specified in the Award Agreement to be executed pursuant to the
Plan and to this Appendix. Each Award Agreement shall state, inter alia, the number of Common Stock to which the Option relates, the type of Option granted thereunder (whether a CGI, OIO, Unapproved 102 Option or a 3(i) Option), the vesting
provisions and the exercise price. 
  

	6.	FAIR MARKET VALUE FOR TAX PURPOSES 

  
 Solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the date of grant the Company’s Common
Stock is listed on any established stock exchange or a national market system or if the Company’s Common Stock will be registered for trading within ninety (90) days following the date of grant of the CGOs, the fair 

  

 - A3 

 
market value of the Common Stock at the date of grant shall be determined in accordance with the average value of the Company’s common stock on the
thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration for trading, as the case may be. 
  

	7.	EXERCISE OF OPTIONS 

  
 Options shall be exercised in accordance with the provisions of Section 9 of the Plan and when applicable, in accordance with the requirements of Section
102. 
  

	8.	ASSIGNABILITY AND SALE OF OPTIONS 

  

	 	8.1	Notwithstanding any other provision of the Plan, no Option or any right with respect thereto, purchasable hereunder, whether fully paid or not, shall be assignable, transferable or
given as collateral or any right with respect to them given to any third party whatsoever, and during the lifetime of the Grantee each and all of such Grantee’s rights to purchase Common Stock hereunder shall be exercisable only by the Grantee.

  

	 	    	Any such action made directly or indirectly, for an immediate validation or for a future one, shall be void. 

  

	 	8.2	As long as Options or Common Stock purchased pursuant to thereto are held by the Trustee on behalf of the Grantee, all rights of the Grantee over the Common Stock are personal, can
not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution. 

  

	9.	INTEGRATION OF SECTION 102 AND TAX ASSESSING OFFICER’S PERMIT 

  

	 	9.1	With regards to Approved 102 Options, the provisions of the Plan and/or the Appendix and/or the Award Agreement shall be subject to the provisions of Section 102 and the Tax
Assessing Officer’s permit, and the said provisions and permit shall be deemed an integral part of the Plan and of the Appendix and of the Award Agreement. 

  

	 	9.2	Any provision of Section 102 and/or the said permit which is necessary in order to receive and/or to keep any tax benefit pursuant to Section 102, which is not expressly specified
in the Plan or the Appendix or the Award Agreement, shall be considered binding upon the Company and the Grantees. 

  

	10.	DIVIDEND 

  
 With respect to all Shares (but excluding, for avoidance of any doubt, any unexercised Options) allocated or issued upon the exercise of Options purchased
by the Optionee and held by the Optionee or by the Trustee, as the case may be, the Optionee shall be entitled to receive dividends in accordance with the quantity of such Shares, subject to the provisions of the Company’s incorporation
documents (and all amendments thereto) and subject to any applicable taxation on distribution of dividends, and when applicable subject to the provisions of Section 102 and the rules, regulations or orders promulgated thereunder. 

 

	11.	TAX CONSEQUENCES 

  

	 	11.1	 Any tax consequences arising from the grant or exercise of any Option, from the payment for Common Stock covered thereby or from any other event or act (of the
Company, and/or its Affiliates, and the Trustee or the Grantee), hereunder, shall be borne solely by the Grantee. The Company and/or its Affiliates, and/or the Trustee shall withhold taxes according to the requirements under the applicable laws,
rules, and regulations, including 

  

 - A4 

	 	 
withholding taxes at source. Furthermore, the Grantee shall agree to indemnify the Company and/or its Affiliates and/or the Trustee and hold them harmless
against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Grantee.

  

	 	11.2	The Company and/or, when applicable, the Trustee shall not be required to release any common stock certificate to an Grantee until all required payments have been fully made.

  

	12.	GOVERNING LAW & JURISDICTION 

  
 This Appendix shall be governed by and construed and enforced in accordance with the laws of the State of Israel applicable to contracts made and to be
performed therein, without giving effect to the principles of conflict of laws. The competent courts of Tel-Aviv, Israel shall have sole jurisdiction in any matters pertaining to this Appendix. 
  

 - A5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00070-of-00352.parquet"}]]